BIOTHERAPIES FOR LIFE Trademark

Trademark Overview

On Wednesday, November 27, 2019, a trademark application was filed for BIOTHERAPIES FOR LIFE with the United States Patent and Trademark Office. The USPTO has given the BIOTHERAPIES FOR LIFE trademark a serial number of 88708639. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 6, 2023. This trademark is owned by CSL BEHRING L.L.C.. The BIOTHERAPIES FOR LIFE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of blood or bleeding disorders, and autoimmune disorders; pharmaceutical preparations and substances to support the function of the human immune system; blood products, namely, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; products derived from recombinant DNA technology, namely, blood clotting factors; antihemophilic factor; Pharmaceutical preparations for the treatment of blood diseases, illnesses and conditions; vaccines
biotherapies for life

General Information

Serial Number88708639
Word MarkBIOTHERAPIES FOR LIFE
Filing DateWednesday, November 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of blood or bleeding disorders, and autoimmune disorders; pharmaceutical preparations and substances to support the function of the human immune system; blood products, namely, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; products derived from recombinant DNA technology, namely, blood clotting factors; antihemophilic factor; Pharmaceutical preparations for the treatment of blood diseases, illnesses and conditions; vaccines
Disclaimer with Predetermined Text"BIOTHERAPIES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL BEHRING L.L.C.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406
Party NameCSL BEHRING L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406

Trademark Events

Event DateEvent Description
Monday, November 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2023SOU EXTENSION 5 GRANTED
Monday, March 6, 2023SOU EXTENSION 5 FILED
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 4 FILED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2022SOU EXTENSION 3 GRANTED
Monday, March 7, 2022SOU EXTENSION 3 FILED
Monday, March 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 7, 2021CORRECTED NOA E-MAILED
Wednesday, October 6, 2021DIVISIONAL PROCESSING COMPLETE
Tuesday, September 28, 2021DIVISIONAL REQUEST RECEIVED
Tuesday, September 28, 2021TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 13, 2021AMENDMENT AFTER NOA NOT ENTERED
Tuesday, September 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 13, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 2 FILED
Tuesday, September 7, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 8, 2021SOU EXTENSION 1 GRANTED
Monday, March 8, 2021SOU EXTENSION 1 FILED
Monday, March 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 9, 2020ASSIGNED TO LIE
Saturday, July 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 24, 2020NON-FINAL ACTION E-MAILED
Friday, January 24, 2020NON-FINAL ACTION WRITTEN
Friday, January 17, 2020ASSIGNED TO EXAMINER
Wednesday, December 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 30, 2019NEW APPLICATION ENTERED

Related Keywords

life biotherapies blood preparations pharmaceutical products clotting factors human namely substances treatment